INTRODUCTION
by on November 11, 2009 www.mcponline.org Downloaded from 4 Numerous cytoplasmic and nuclear proteins are post-translationally modified with O-linked β-Nacetylglucosamine (O-GlcNAc). GlcNAcylation is involved in almost all aspects of cellular metabolism (1) and is highly dependent on the nutrient status of the cell (2) . The O-GlcNAc modification rivals phosphorylation in both abundance and protein distribution. Recent studies indicate that signaling pathways can be regulated by the interplay of these two modifications at the same or proximal sites on numerous protein substrates. has been largely unsuccessful because of low binding avidity (4) . Long, wheat germ agglutinin (WGA) lectin columns (~39 ft) provide some enrichment, but also bind strongly to complex glycans (5) . A mutant galactosyltransferase (GalT1) has been used to label GlcNAcylated proteins with a ketonecontaining galactose analog (6) . Following proteolytic digestion, O-GlcNAc modified peptides were biotinylated with hydrazine chemistry, isolated on a column packed with avidin beads, eluted with free biotin, and sequenced by ETD mass spectrometry. Failure to elute peptides with high efficiency from the by on November 11, 2009 www.mcponline.org Downloaded from 5 avidin column and an inability to direct the fragmentation to the peptide backbone, limits the usefulness of this approach. Reported here is an enrichment methodology that: (a) is highly specific for O-GlcNAc modified peptides, (b) provides for efficient release of the captured peptides from an affinity support, and (c) facilitates complete characterization of the released peptides by ETD mass spectrometry.
EXPERIMENTAL PROCEDURES
Reagents and Chemical Synthesis. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise noted. PC-PEG-Biotin-Alkyne reagent (Reagent 1 in Fig. 1a ) containing a photocleavable 1,2-(nitrophenyl) ethyl moiety (PC-PEG-Biotin, synthesized according to Olejnik et. al. (9) or obtained from Ambergen, Watertown, MA) was prepared by treating the corresponding Nhydroxysuccinimidyl ester with 10-fold excess of propargylamine (Sigma, St. Louis, MO) ) in dry methanol at room temperature for 4 hrs in the dark. The total reaction volume was 20 µl containing 5 mg PC-PEG-Biotin (6 umol) and 4 µl propargylamine (60 umol). Product (PC-PEG-Biotin-Alkyne) was purified by thin layer chromatography (250 microns silica gel plate, Analtech, Newark, DE) with methanol/chloroform (1:9, v/v) as the mobile phase. The product is located on the thin layer plate by brief exposure (< 1 second) to 254 nm U.V. light and extracted by scraping the thin-layer zone into dry methanol. Silica gel is removed by centrifugation. Identity of the product is confirmed by mass spectrometry (Supplement Figure 4) . The yield is greater than 98%. The purified product was stored in methanol at -20 °C until use. Western blotting with HRP-conjugated avidin. α-Crystallin (Invitrogen, Carlsbad, CA) was subjected to chemoenzymatic tagging as described above but without SCX and avidin enrichment. Supernatant was passed through a 1 µm filter and concentrated with a 10 kDa molecular weight cut-off membrane with simultaneous buffer exchange to 10 mM HEPES, pH 7.5. Proteins (1.9 mg) were fractionated on Suparose 12 PC 3.2/30 gel filtration column (GE Healthcare) by using a buffer containing 20 mM HEPES and 50 mM NaCl, pH 7.5. Tau containing fractions were combined. Total protein amount was estimated by absorbance at UV 280 nm. An aliquot of this material (about 1.3 µg)
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was used for O-GlcNAc site mapping. gradient-eluted into the mass spectrometer at a flow rate of 60 nL/min. ETD MS/MS spectra were acquired using the following parameters (reaction time=100 milliseconds, reagent AGC target=4E5 ion counts, full AGC target= 2E4 ion counts, MSn AGC target=2E4 ion counts, isolation window= 3 m/z, repeat count=2, repeat duration=20 seconds, exclusion duration=30 seconds).
LC-MS Analysis of Tagged and Enriched O-GlcNAc Modified
Analysis of Mass Spectrometry Data. Peak lists were generated from raw data files using Bioworks software (version 3.3.1 sp1). In-house developed software was used to remove charge reduction species.
Open Mass Spectrometry Search Algorithm (OMSSA) (version 2. 
RESULTS AND DISCUSSION

Approach for highly specific enrichment and site-mapping of GlcNAcylation
For this enrichment approach (Figure 1a ), proteins were first proteolytically digested. Following this, GlcNAcylated sites were labeled with an azido sugar using the substrate UDP-Nazidoacetylgalactosamine (UDP-GalNAz) the galactosyltransferase GalT1 (6). Since the UDP product formed in this reaction potently feedback inhibits GalT1, alkaline phosphatase was added to the reaction mixture to rapidly degrade UDP and to ensure complete derivitazation. (Supplementary Fig. 3 online) .
Peptide: N-Glycosidase F (PNGase F), which removes N-linked glycans, was also added to the reaction mixture to ensure N-glycans with terminal GlcNAc residues were not labeled with GalNAz. Excess . The elution efficiency is also low when using monomeric avidin. Therefore harsh conditions are generally used for elution from avidin beads; however, this can easily damage OGlcNAc. Reduction-cleavable biotin is not suitable for this application because the dipolar addition reaction requires strong reducing conditions. Acid-cleavable biotin typically requires treatment with 95% trifluoroacetic acid, which we also find is strong enough to partially hydrolyze O-GlcNAc.
Olejnik et. al. (9) previously reported a photocleavable biotin reagent. Based on their findings, we synthesized a photocleavable biotin-alkyne reagent to tag GlcNAc modified peptides (Fig. 1a, inset) .
This photocleavable biotin-linked alkyne contains a terminal biotin group, which facilitates enrichment of GlcNAc modified peptides. In addition, after enrichment with avidin chromatography, the tagged GlcNAc modified peptides are efficiently released upon brief exposure to UV light (365 nm) (Supplemental Figure 4) and the released peptides carry a basic aminometyltriazolylacetylgalactosamine group. This overall approach is illustrated in Figure 1a . Shown in Figure 1b conditions. Cleavage at the glycosidic linkage is not observed.
Detecting GlcNAcylation in α-crystallin
To test our enrichment strategy, we analyzed a mixture containing tryptic peptides from α-crystallin (50 fmol), which has two known O-GlcNAc sites, and bovine serum albumin (2.5 pmol). GlcNAc peptides were tagged with GalNAz followed by photocleavable-biotin, enriched and subsequently released from an avidin resin, and analyzed by CAD using a LTQ-Orbitrap mass spectrometer and by ETD using a LTQ XL mass spectrometer. Shown in Figure 2a crystallin is approximately 10% (11) . Knowing this, we estimate that recovery of the two O-GlcNAc modified peptides from α-crystallin is over 90%.
Next, we asked if this tagging strategy could be employed to detect O-GlcNAc at the intact protein level without using mass spectrometry. As shown in Figure 2c , tagged α-crystallin was readily detectable by avidin-HRP blotting. In contrast, the signal disappeared when the tagged protein was illuminated by UV before the sample was resolved by SDS-PAGE. We conclude that tagged proteins by on November 11, 2009 www.mcponline.org
Downloaded from
11 and proteins bound non-specifically to the avidin beads can be readily distinguished by blotting samples before and after the photochemical cleavage.
Detecting and site-mapping GlcNAcylation in complex biological sample
The described protocol was used to analyze tau-containing protein fractions obtained from rat brain.
These fractions were isolated by a combination of perchloric acid extraction and gel filtration chromatography. Eight O-GlcNAc sites on 7 different proteins were identified ( Table 1 and Figure 3a is the ETD mass spectrum recorded on
Supplementary Figure 5 online). Shown in
[M+3H] +3 ions from residues 709-717 of the tau microtubule associated protein. Note that the mass difference between both c 3 and c 2 and z 7 and z 6 is 589 Da rather than the 87 Da expected for an unmodified Ser residue. We conclude that Thr711 (more commonly known as Thr400 according to the most common splice variant) in the carboxyl terminal region of tau is O-GlcNAc modified. This same site can also be phosphorylated by glycogen synthase kinase-3β (GSK-3β) (12) . These data support our hypothesis that one function of O-GlcNAc on tau is to prevent hyperphosphorylation in normal brain (13, 14) . Since we observed limited digestion of tau with trypsin, we anticipate that additional O-GlcNAc sites will be detected when multiple proteases are employed to extend the sequence coverage.
From the same tau containing protein fractions, O-GlcNAc sites on α -, β -, and γ -synuclein (Table 1) were also characterized. α-, β -, and γ -synuclein are three small proteins that are expressed primarily in neural tissues (15) . Aggregated α -synuclein is a component of filamentous inclusions associated with neurodegenerative conditions, such as Alzheimer's and Parkinson's disease (16). Here we report that α-synuclein is O-GlcNAc modified on Thr72, a residue located within a 35 amino acid stretch that forms the protease-resistant core of α -synuclein fibrils (15) . This region is prone to selfaggregation and is able to seed the formation of amyloid fibrils (17) . It seems likely that GlcNAcylation on this peptide could prevent fibril formation. Interestingly, Shimura et. al. (18) reported that the E3 ubiquitin protein ligase, parkin, binds and ubiquinates glycosylated α -synuclein, but not the non- glycosylated form in human brain, although the identity and site of the glycosylation were unknown at that time.
Two O-GlcNAc were also identified son the methyl-CpG-binding protein (MeCP2). One site was unambiguously identified at Thr434 (Fig. 3b) while the second site was localized to either Thr443 or Thr444. This protein is also of interest since it binds to methylated DNA and mediates transcriptional repression through interactions with a histone deacetylase and corepressor SIN3A (19) . Mutations in MeCP2 cause Rett syndrome, a developmental disorder characterized by mental retardation, motor dysfunction, and autistic behavior (20) . Brain specific phosphorylation of Ser421 in MeCP2 by a CaMKII-dependent mechanism is thought to regulate a program of gene expression that mediates nervous system maturation (21). Whether or not GlcNAcylation on the nearby residues (T434 and either T442 or T443) alters this process will require further investigation.
In summary, we describe here an efficient enrichment protocol that is highly specific for OGlcNAc modified proteins and peptides, and that facilitates site mapping of O-GlcNAc modified amino acids at the low femtomole level by ETD mass spectrometry. The procedure employs a novel photocleavable biotin tag that allows for efficient release of the enriched O-GlcNAc modified peptides from the solid affinity support. In addition, the photocleavage reaction leaves a basic aminomethyltriazole tag at the site of the O-GlcNAc modification. As a result, all modified, tryptic peptides exist in a charge state of +3 or higher, and thus fragment efficiently along the peptide backbone when subjected to ETD. For site-specific O-GlcNAc quantification, a heavy isotope labeled photocleavable biotin alkyne is currently being synthesized.
Because the enrichment procedure is highly specific, the flow-through from the avidin- we have mapped, quantified, and compared relative site occupancy for over 120 specific O-GlcNAc modified residues and over 350 phosphorylated residues by tandem mass spectrometry using only 15 µg of sample from a spindle/midbody preparation. This confirms the robustness of our protocol for analysis of complex mixtures (Wang et al., submitted) . Since the sensitivity of the above approach is already on par with that used to study protein phosphorylation, we expect that the method will be a valuable tool for deciphering the "O-GlcNAcome". Together with other methods (6, 22) , we expect a significant increase of known O-GlcNAc sites in the very near future, which will highly facilitate investigation of the function of GlcNAcylation. 
